Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
40
NCT07144527
Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
Phase: N/A
Role: Collaborator
Start: Sep 15, 2025
Completion: Nov 1, 2026